Kura Oncology Inc (NASDAQ:KURA)
| 30.61 BATS BZX Real-Time Price As of 3:56pm ET |  +0.53 / +1.76%Today’s Change | 6.35 Today|||52-Week Range 30.68 | +122.62% Year-to-Date |
Latest KURA News | Press Releases
| Sector Watch: More oncology events as cancer ETF breaks out Sep 20 / Seeking Alpha - Paid Partner Content |
Today’s Trading
| Previous close | 30.08 |
| Today’s open | 29.98 |
| Day’s range | 29.98 - 30.68 |
| Volume | 11,201 |
| Average volume (3 months) | 613,708 |
| Market cap | $1.7B |
Data as of 3:56pm ET, 09/29/2020
Growth & Valuation
| Earnings growth (last year) | +12.37% |
| Earnings growth (this year) | -9.64% |
| Earnings growth (next 5 years) | +16.24% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 6.22 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| RVNCRevance Therapeutics... | -0.19 | -0.73% |
| PBHPrestige Consumer He... | -0.04 | -0.11% |
| ---- | ||
| CYTKCytokinetics Inc | -0.02 | -0.09% |
Data as of 3:57pm ET, 09/29/2020
Financials
| Next reporting date | November 9, 2020 |
| EPS forecast (this quarter) | -$0.40 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$63.1M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
